Business & Consumer Services » Business Services | Parallax Health Sciences Inc.

Parallax Health Sciences Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
11,579.70
22,749.10
94.90
11.70
Cost of Goods Sold (COGS) incl. D&A
18.60
12.20
8.00
9,952.10
19,402.10
225.80
141
Gross Income
18.60
12.20
8.00
1,627.60
3,346.90
130.80
129.20
SG&A Expense
482.60
473.40
858.70
2,779.70
6,483.80
3,917.80
6,432.10
EBIT
501.10
485.60
866.70
-
3,136.90
-
6,561.30
Unusual Expense
-
-
-
110.00
4,026.90
-
23,215.90
Non Operating Income/Expense
42.40
1.70
-
10.20
0.20
-
4,478.30
Interest Expense
11.20
20.60
246.60
2,447.70
6,018.20
6,466.80
4,019.10
Pretax Income
554.70
504.50
1,113.20
3,719.90
13,181.90
10,511.40
17,113.70
Consolidated Net Income
554.70
504.50
1,113.20
3,719.90
13,181.90
10,511.40
17,113.70
Net Income
554.70
504.50
1,113.20
3,719.90
13,181.90
10,511.40
17,113.70
Net Income After Extraordinaries
554.70
504.50
1,113.20
3,719.90
13,181.90
7,357.80
17,938.10
Net Income Available to Common
554.70
504.50
1,113.20
3,719.90
13,181.90
13,664.90
16,289.30
EPS (Basic)
0.01
0.00
0.01
0.03
0.12
0.11
0.08
Basic Shares Outstanding
107,722.60
150,699.10
127,492.90
131,734.50
113,689.00
120,493.60
148,335.70
EPS (Diluted)
0.01
0.00
0.01
0.03
0.12
0.11
0.08
Diluted Shares Outstanding
107,722.60
150,699.10
127,492.90
131,734.50
113,689.00
120,493.60
215,576.20
EBITDA
482.60
473.40
858.70
1,074.20
2,922.70
3,960.90
6,440.70

About Parallax Health Sciences

View Profile
Address
1327 Ocean Avenue
Santa Monica California 90401
United States
Employees -
Website http://www.parallaxhealthsciences.com
Updated 07/08/2019
Parallax Health Sciences, Inc. engages in development of pharmaceutical solution, infertility and neurosciences. It is a bio-medical company focuses on personalized patient healthcare. The firm owns a compounding pharmacy capable of specific patient therapy with a diagnostic testing platform capable of diagnosing and monitoring medical conditions tests that diagnose and/or accessible, practical and rapid point of care in vitro diagnostics.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.